News & Analysis on Clinical Trial Services & Contract Research And Development
People on the move
By Melissa Fassbender
- Last updated on
The UK-based drug discovery services CRO has appointed Dr. Kevin Doyle as head of chemistry.
According to the company, the appointment strengthens its expanding team of international scientists – the number of which has grown by more than 50% in the last 18 months.
Doyle is a medicinal chemist and joins Domainex Charles River Laboratories. He has also worked at BASF and OSI Pharmaceuticals.
"I am delighted to have joined team at Domainex," he told us. "Domainex is clearly a rapidly-growing CRO and has been ‘one to watch’ for some time now. The opportunity to be a part of it, and to help shape the future of its medicinal chemistry was one that I could not miss."
Doyle said he has already met with some of the company's clients.
"Domainex has an ambitious strategy which is already seeing us support an increasing number of clients from around the world," he added. "I am relishing the opportunity to join the organization at such an exciting time, and look forward to working with the team to further develop the high-class science that we offer to our clients."